Skinmed最新文献

筛选
英文 中文
ZelsuvmiTM (Berdazimer) Topical Gel.
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Aditya K Gupta, Avantika Mann, Kimberly Vincent, William Abramovits
{"title":"Zelsuvmi<sup>TM</sup> (Berdazimer) Topical Gel.","authors":"Aditya K Gupta, Avantika Mann, Kimberly Vincent, William Abramovits","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Zelsuvmi<sup>TM</sup> (berdazimer) topical gel has been approved recently for the treatment of molluscum contagiosum (MC) in patients aged ≥1 year. In three phase 3, randomized, double-blind, vehicle-controlled trials of similar design, berdazimer was investigated for the treatment of MC. Berdazimer or vehicle was applied once daily on MC lesions until complete lesion clearance was observed or for up to 12 weeks. Berdazimer demonstrated higher efficacy in achieving the primary outcome at week 12 (Trial 1, berdazimer: 32.4% [144/444] and vehicle: 19.7% [88/447]; Trial 2, berdazimer: 30% [71/237] and vehicle: 20.3% [24/118]; and Trial 3, berdazimer: 26% [61/236] and vehicle: 22% [28/126]), compared to vehicle. Common adverse events were the mild to moderate reactions, including application site pain, dermatitis, exfoliation, erythema, pruritus, and lesions.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"460-462"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teledermatology: What Is the Viewpoint of an AI-Powered Chatbot? 远程皮肤科:人工智能聊天机器人的观点是什么?
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Ahmad Alabdulkareem
{"title":"Teledermatology: What Is the Viewpoint of an AI-Powered Chatbot?","authors":"Ahmad Alabdulkareem","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"419-420"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The First Patient with Tinea Manuum because of Trichophyton erinacei Isolated in Malta. 马耳他首例由毛癣菌引起的手痒患者。
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Jonathan Young, Alicia Dimech, Victoria Bondin, Angelique Lofaro, Jessica Marie Vella, Andrea Luigi Galea, Arianne Muscat, Liam Mercieca
{"title":"The First Patient with Tinea Manuum because of <i>Trichophyton erinacei</i> Isolated in Malta.","authors":"Jonathan Young, Alicia Dimech, Victoria Bondin, Angelique Lofaro, Jessica Marie Vella, Andrea Luigi Galea, Arianne Muscat, Liam Mercieca","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 39-year-old woman presented to the dermatology department in January 2022 with a 3-week history of a progressively enlarging and intensely pruritic erythematous annular nodule on her left hand. The lesion started as a small blister, which was initially presumed to be a flare up of her pompholyx dermatitis. On her physician's advice, she applied clobetasol propionate ointment twice daily for 5 days; however the blister continued to increase in size until it burst, revealing raw inflamed skin. As the patch continued to increase in size, she was prescribed oral ciprofloxacin 500 mg twice a day for 5 days; however, the constantly weeping lesion grew to around 3 cm in diameter. The associated pruritus also became intense, without any response to regular antihistamines and ice application and disturbing patient's sleep. She also applied regular povidone iodine dressings but without any effect. Apart from pompholyx dermatitis, her medical history was significant for hypermobile Ehlers Danlos syndrome type 3 (hEDS).</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"475-477"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Edward L. Keyes Resident Contest for Outstanding Case Reports. 爱德华·l·凯斯杰出案例报告驻地竞赛。
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Vesna M Petronic-Rosic
{"title":"Edward L. Keyes Resident Contest for Outstanding Case Reports.","authors":"Vesna M Petronic-Rosic","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"485"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MOHS Patients Can Reliably Estimate Preoperative Non-Melanoma Skin Cancer Size. MOHS患者可以可靠地估计术前非黑色素瘤皮肤癌的大小。
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Gabrielle M Rivin, Spencer Dunaway, Matthew Olagbenro, Zachary Carter, Alan B Fleischer, Scott A Neltner
{"title":"MOHS Patients Can Reliably Estimate Preoperative Non-Melanoma Skin Cancer Size.","authors":"Gabrielle M Rivin, Spencer Dunaway, Matthew Olagbenro, Zachary Carter, Alan B Fleischer, Scott A Neltner","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>As the presurgical size and anatomic location of non-melanoma skin cancer correlates to the complexity of Mohs micrographic surgery (MMS), patients are frequently asked to self-report their preoperative tumor size to aid in efficient scheduling and triage. We aimed to assess the accuracy of patient's self-reported lesion measurements prior to MMS by comparing patient's estimates of lesion size to the measurements taken by a Mohs surgeon. We conducted a retrospective chart review of 1,000 patients who underwent MMS and self-reported their lesion size at a preoperative telehealth visit. The patients reported their lesion size in one dimension (1D)/two dimensions (2D) or using a pencil eraser as a size reference. Patients demonstrated excellent reliability (intra-class correlation coefficient [ICC]: 0.916) while reporting their lesion size in two dimensions, and moderate reliability (ICC: 0.644) while reporting their lesion size in one dimension. Patients had slight agreement (κ = 0.178) with the surgeon's preoperative measurement while using a pencil eraser as a size reference. Dermatology practices must be encouraged to utilize telehealth to obtain presurgical size estimates from patients using 1D or 2D size measurements. By utilizing presurgical size estimates, surgeons can better triage and schedule patients to provide appropriate anticipatory guidance to patients and their caretakers.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"438-442"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermatologic Manifestations in Chronic Kidney Disease Patients. 慢性肾病患者的皮肤病学表现。
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Chandan Singh, Neel Prabha, Vinay Rathore
{"title":"Dermatologic Manifestations in Chronic Kidney Disease Patients.","authors":"Chandan Singh, Neel Prabha, Vinay Rathore","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Various specific and nonspecific dermatologic abnormalities are observed in chronic kidney disease (CKD). Dermatologic manifestations are observed at all stages of CKD and these increase with increasing duration and severity of the renal disease. Most of the studies in the literature have focussed mainly on dermatologic manifestations associated with dialysis and end-stage renal disease. We conducted a cross-sectional study to determine the prevalence, patterns, and risk factors of dermatologic disorders in CKD patients irrespective of clinical stage or status of dialysis.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"443-450"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Features, Treatments, and Therapeutic Outcomes of Peristomal versus Non-Peristomal Pyoderma Gangrenosum in 45 Patients with Inflammatory Bowel Disease: A Single-Institution Study, 2002 through 2021. 45例炎症性肠病患者的肠周性与非肠周性坏疽性脓皮病的特征、治疗和治疗结果:2002年至2021年的单机构研究
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Omkar Mayur, Rebeca Martinez, Jean S McGee
{"title":"Features, Treatments, and Therapeutic Outcomes of Peristomal versus Non-Peristomal Pyoderma Gangrenosum in 45 Patients with Inflammatory Bowel Disease: A Single-Institution Study, 2002 through 2021.","authors":"Omkar Mayur, Rebeca Martinez, Jean S McGee","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Pyoderma gangrenosum (PG) is the second most common skin manifestation reported in patients with inflammatory bowel disease (IBD). We performed a single-institution, retrospective study to summarize the clinical features and examine effective treatment regimens and outcomes of PG in IBD patients. We identified 45 patients who presented to our institute between January 1, 2002 and December 31, 2021 with the following criteria: (1) diagnosed with an active PG (ICD9: 686.01, ICD10: L88) during the specified period, (2) aged at least 18 years at the time of diagnosis, (3) had the diagnosis of IBD, and (4) documented treatment regimens/outcomes. In our cohort, 56% of the patients had PG at the site of stoma. Intralesional and oral steroids were the most utilized therapies for peristomal PG (PPG) and non-peristomal PG (NPPG) in 60% and 62% of the patients, respectively. The bowel manifestations were under control at the time of PG diagnosis in 76% of PPG patients, compared to 43% of NPPG patients. Our findings demonstrated that PPG in IBD patients could be managed locally with intralesional steroids only, as the bowel manifestations of PPG patients tend to be under control, compared to those of NPPG patients.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"433-436"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicentric Reticulohistiocytosis.
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Leah A Goldberg, Sylvia Hsu
{"title":"Multicentric Reticulohistiocytosis.","authors":"Leah A Goldberg, Sylvia Hsu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A Caucasian woman in her twenties having asymptomatic papules on the hands for the past 6 months was referred by rheumatology for a skin biopsy. The patient had presented to rheumatologist for arthralgia. On physical examination, multiple, dull red, 2-5-mm papules were observed on her dorsal fingers, with most in the periungual regions. No papules or nodules were discovered on the mucosal membranes or other areas of her skin. Given the presence of characteristic \"coral beads\" along the periungual regions, the clinical diagnosis of multicentric reticulohistiocytosis (MRH) was rendered. A 4-mm punch biopsy revealed histiocytes with eosinophilic, homogenous, and finely granular \"ground glass\" cytoplasm.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"452-453"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Filsuvez® (Birch Triterpenes) Topical Gel. Filsuvez®(桦木三萜)外用凝胶。
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Aditya K Gupta, Avantika Mann, Kimberly Vincent, William Abramovits
{"title":"Filsuvez<sup>®</sup> (Birch Triterpenes) Topical Gel.","authors":"Aditya K Gupta, Avantika Mann, Kimberly Vincent, William Abramovits","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Filsuvez<sup>®</sup> (birch triterpenes) topical gel received approval in 2023 for the treatment of epidermolysis bullosa (EB) in pediatric patients (aged ≥6 months) and adults. It promotes wound healing by modulating inflammation, encouraging new tissue formation, and maintaining the skin barrier. In a randomized, double-blind, controlled, parallel-group, phase III trial (EASE, NCT03068780), 223 patients were randomly assigned to two groups: the first group received treatment with birch triterpenes topical gel (study gel, n = 109), and the second group received treatment with vehicle gel (n = 114). The study gel or vehicle gel was applied as a 1-mm layer to the affected wound surface once every 4 days for 90 days. The primary efficacy endpoint, defined as the first complete closure of the EB target wound by day 45, was achieved at a higher proportion in the study gel group (41.3% [45/109]), compared to the vehicle gel group (28.9% [33/114]). Application site reactions were reported in 7.3% (8/109) of patients in the study gel group and 6.1% (7/114) of patients in the vehicle gel group. It is recommended to apply as a 1-mm layer to the affected wound surface only.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"463-465"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large Nevus Lipomatosus Cutaneous Superficialis in the Skin of Color. 大的浅皮肤脂肪瘤痣。
Skinmed Pub Date : 2024-12-31 eCollection Date: 2024-01-01
Janet Choi, Kelly Hawkins, Eliza Balazic, Bijal Amin, Kseniya Kobets
{"title":"Large Nevus Lipomatosus Cutaneous Superficialis in the Skin of Color.","authors":"Janet Choi, Kelly Hawkins, Eliza Balazic, Bijal Amin, Kseniya Kobets","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 15-year-old African-American man (Fitzpatrick skin type V) presented to the outpatient dermatology clinic with a large, verrucous, exophytic mass measuring 3.5 × 2.3 cm on the right lateral side of the posterior flank (Figure 1). The lesion had been increasing in size for several years. His mother had refused a shave excision when he was 9 years old. He also had atopic dermatitis, acanthosis nigricans, and benign melanocytic nevi. He was obese with borderline hypercholesterolemia.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":"22 6","pages":"469-470"},"PeriodicalIF":0.0,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信